Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative Nerve Block in Foot and Ankle Surgery
NCT04022057Phase 3Withdrawn
- Sponsor
- University of Alberta
- Start
- Aug 2019
- Primary completion
- Mar 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of ropivacaine in ankle arthropathy, ankle arthritis, sponsored by University of Alberta. Planned start Aug 2019; status: withdrawn.
02
Drugs
ropivacaine
03
Conditions
ankle arthropathyankle arthritis
Beyond the preview
Go deeper on NCT04022057.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04022057.